Lab Resources

The ICTR laboratories provide coordinated help across several related programs, all focused on the foundational components required to effectively translate new drugs, biologics, vaccines, devices, biomarkers and diagnostics into clinical trials and eventually clinical practice.

Biologics Translational Program

Offers biologic product development and testing Consultative support for biologic development Preclinical testing to clinical production.

Read more

Cardiovascular Imaging Laboratory

Provides echocardiographic and carotid imaging for approved CRU protocols, as well as measurement of endothelial function and arterial stiffness.

Read more

Clinical Research Unit Core Laboratory

Offers 87 distinct assays of clinical chemical endpoints and biomarkers to support ICTR research protocols and is designed to serve investigators at all clinical research unit locations.

Read more

Imaging Translational Program

Facilitates one-on-one consultation with imaging experts for study design, imaging protocol development and study implementation.

Read more

Genetics Translational Technology Program

Bridges the gap between clinical genetic testing and research-driven molecular technologies with consulting and laboratory services and assistance with translation of molecular technologies to the clinical environment.

Read more

Drug Screening, Development & Analysis Units

Maintains, distributes, and screens drug library (FDA approved) compounds. This unit is ideal for re-purposing licensed drugs by screening activity against new targets.

Read more

Proteomic Biomarker Development Program

Couples mass spectrometry to one and two dimensional separations by column chromatography or gel electrophoresis to identify, quantify or characterize proteins.

Read more

Metabolomics Program

Provides consultation to basic, clinical, and translational research teams regarding the feasibility, design, and costs of projects using metabolomics technologies.

Read more

Medicinal Chemistry Unit

Synthesizes small molecule when it is not commercially available and supports structure-activity relationship studies.

Read more